+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

The Edmond J. Safra Fellowship in Movement Disorders

The Michael J. Fox Foundation

The Edmond J. Safra Fellowship in Movement Disorders aims to grow the global base of movement disorder specialists — neurologists with additional training in Parkinson's disease and other movement disorders — by training movement disorder clinician-researchers who can provide expert care and lead scientific advances.

As the demand for movement disorder specialists increases, not enough neurologists are receiving vital training in Parkinson’s and related conditions. To address this need, The Michael J. Fox Foundation (MJFF), in collaboration with longtime partner the Edmond J. Safra Foundation, launched the Edmond J. Safra Fellowship in Movement Disorders. The program annually funds academic centers to train a new movement disorder clinician-researcher over a two-year period and is growing an international, collaborative network of next-generation leaders in Parkinson’s research and care.

History

Since its introduction in 2014, the Edmond J. Safra Fellowship in Movement Disorders has annually funded five international academic medical centers to each train a new movement disorder clinician-researcher over two years. Thanks to increased support from the Edmond J. Safra Foundation, MJFF expanded annual funding to 10 centers beginning with the Class of 2025.

AI Based Application Success Predictor

🧠 Patient-Relevant, High-Impact Science

Proposals must address clear questions with potential to improve the lives of people with Parkinson’s—e.g., biomarker discovery, therapeutic development, patient-reported outcomes—all aligned to the specific grant call’s aims .

2. 🎯 Translational Focus & Pathway

MJFF prioritizes projects that translate basic science into patient therapies—such as compound screening, mechanism validation, early clinical testing, and biomarker integration .

Clear strategies to move from bench to bedside—including regulatory/commercial strategy—are vital.

3. 🤝 Collaboration, Open Science & Shared Resources

They fund consortia and expect research to contribute open-access data, reagents, or tools (e.g., biosamples from Fox Insight or PPMI) .

Proposals should incorporate open sharing and community engagement.

4. ⏱️ Expedient Review & Strict Deadlines

MJFF operates a fast-paced process: decisions within 6 weeks to 3 months after full submission .

They enforce deadlines strictly—no extensions—so applications must be timely and available for post-deadline follow-up .

5. 📐 Budget Appropriateness & Cost Transparency

Budgets must align with MJFF definitions; indirect costs are capped (usually 10–15%). Proposals using external templates (e.g., NIH) risk disqualification .

6. 📚 Strong Track Record & Program Fit

Investigators should demonstrate relevant experience and prior success (e.g., in biomarker, target validation, or therapeutic pipelines). Proposals must align with MJFF program themes—such as the Targets to Therapies initiative, therapeutic pipelines, biomarker validation, or prodromal trials .

7. ⚙️ Data/Biosample Access & Use of MJFF Tools

Utilizing MJFF resources—like PPMI data, Fox Insight tools, or Foundation antibodies—and integrating them into the proposal enhances credibility .

8. 👥 Consortium & Industry Partnerships

Many MJFF programs welcome (or require) industry/academic collaborations, especially in preclinical pipelines or trial readiness (e.g., LRRK2 Safety Initiative forged despite competition).

✅ Summary Table

Predictor	What Applicants Should Do
Patient-centered questions	Tie project goals to meaningful PD outcomes
Translational pathway	Outline plans from discovery to clinical testing
Open science & resource sharing	Commit to data/tool sharing platforms
Strict timing	Submit before deadline, plan for follow-up
Budget compliance	Use MJFF formats, respect cost caps
Thematic alignment & PI strength	Match your expertise to foundation priorities
Foundation resource integration	Incorporate MJFF tools or platforms
Cross-sector collaboration	Engage clinical, academic, and industry partners

Specialties

Neurosciences

Eligibility Requirements

The program grants funding directly to academic centers, which then must identify and train a new movement disorder clinician-researcher over a two-year period. Grant support cannot be used for a fellow already enrolled or selected. These funds may cover the fellow’s stipend, benefits and travel allowance as well as coursework, conferences, and other relevant educational and training opportunities. No indirect costs may be claimed for this award.

The Edmond J. Safra Fellowship in Movement Disorders is open to academic centers worldwide. Previously awarded centers may apply, with the exception of those funded in the most recent round and those currently training an Edmond J. Safra Fellow.

Sponsor Details

Sponsor Institute/Organizations: The Michael J. Fox Foundation

Sponsor Type: Corporate/Non-Profit

Address: P.O. Box 4777 New York, NY 10163-4777

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity